Plain-English translation of NCT06557018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a newer form of a numbing medication that releases slowly over time, to help reduce pain after total knee replacement surgery. Researchers want to see if this medication works better and is safer than the current standard pain relief injections used during knee surgery. The goal is to help patients have less pain after surgery, need fewer opioid painkillers, and recover faster.
After knee replacement surgery, pain is a major problem that slows down recovery and increases the need for strong opioid medications. This medication has been developed to provide longer-lasting pain relief from a single injection, which could improve patient satisfaction and reduce complications and hospital stays.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo knee replacement surgery as planned. During surgery, your surgical team will inject either the new medication or the standard pain relief injection into the tissues around your knee at the end of the procedure. After surgery, you will be monitored and asked regularly about your pain levels using a simple pain scale. Your recovery, pain management, and any side effects will be tracked during your hospital stay and follow-up visits.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China